Acute Hepatic Porphyria (AHP)
View the latest scientific data presented at congress events in the past 2 years and discover peer-reviewed publications related to AHP.
The information on this page pertains to select congress and publication resources. It is not intended to serve as a comprehensive list of all congress and publications resources.
Publications
Acute Hepatic Porphyria (AHP)
Disease burden in patients with acute hepatic porphyria: experience from the phase 3 ENVISION study
Orphanet Journal of Rare Diseases
Acute Hepatic Porphyria (AHP)
Patient Perspective on Acute Hepatic Porphyria with Sporadic Attacks: A Chronic Disease with Substantial Health-Related Quality of Life Impacts
Advances in Therapy
Acute Hepatic Porphyria (AHP)
A Drug-Drug Interaction Study Evaluating the Effect of Givosiran, a Small Interfering Ribonucleic Acid, on Cytochrome P450 Activity in the Liver
Clinical Pharmacology and Therapeutics
Acute Hepatic Porphyria (AHP)
Normal reference ranges for urinary δ-aminolevulinic acid and porphobilinogen levels
JIMD Reports
Acute Hepatic Porphyria (AHP)
Detecting rare diseases in electronic health records using machine learning and knowledge engineering: Case study of acute hepatic porphyria
PLOS One
Acute Hepatic Porphyria (AHP)
Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria
New England Journal of Medicine
